A RELATIVE BIOAVAILABILITY STUDY OF THE GRAZOPREVIR/ELBASVIR FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS

被引：0
|
作者：
Davit, B. M. [1 ]
Alon, A. [1 ]
Caro, L. [2 ]
Feng, H. [2 ]
Guo, Z. [2 ]
Kesisoglou, F. [2 ]
机构：
[1] Merck Res Labs, Rahway, NJ USA
[2] Merck Res Labs, N Wales, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-137
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [41] FIXED-DOSE COMBINATION OF TRIMETHOPRIM
    WEISSMAN, JB
    NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (25): : 1364 - 1365
  • [42] Bioequivalence and food effect assessment for vildagliptin/metformin fixed-dose combination tablets relative to free combinations of vildagliptin and metformin in Japanese healthy subjects
    Mita, Sachiko
    Chitnis, Shripad D.
    Kulmatycki, Kenneth
    Salunke, Atish
    Het, Yan-Ling
    Zhou, Wei
    Suzuki, Hikoe
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 305 - 314
  • [43] The bioavailability of a fixed-dose combination of olmesartan medoxomil and amlodipine besylate is unaffected by food
    Haworth, S.
    Heyrman, R.
    Bathala, M.
    Lee, J.
    Noveck, R.
    Rohatagi, S.
    Marier, J. F.
    Rubets, I.
    Salazar, D.
    JOURNAL OF HYPERTENSION, 2007, 25 : S237 - S238
  • [44] Relative Bioavailability of Fixed-Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male Volunteers
    Burns, Olivia
    Zhu, John
    Manyak, Michael J.
    Ravindranath, Ramiya
    Koosha, Fariba
    Haque, Nazneen
    Chung, Sally
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (04): : 422 - 434
  • [45] Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability
    de Bruin, Tjerk W. A.
    Reele, Stots
    Hamer-Maansson, Jennifer E.
    Parikh, Shamik
    Tang, Weifeng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (02): : 118 - 130
  • [46] EFFECT OF FOOD AND ACID REDUCING AGENTS ON THE RELATIVE BIOAVAILABILITY AND PHARMACOKINETICS OF SOFOSBUVIR/VELPATASVIR FIXED-DOSE COMBINATION TABLET.
    Mogalian, E.
    OsinusiAnu
    Shen, Gong
    Sajwani, Karim
    McNallyJohn
    LingJohn
    MathiasAnita
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S43 - S44
  • [47] PHARMACOKINETIC COMPARISON BETWEEN A FIXED-DOSE COMBINATION OF ATORVASTATIN/OMEGA-3 AND THE CORRESPONDING LOOSE COMBINATION IN HEALTHY KOREAN SUBJECTS
    Khwarg, J.
    Lee, S.
    Oh, J.
    Kang, W.
    Lee, H.
    Kim, K.
    Jeong, K.
    Won, C.
    Choi, Y.
    Ha, D.
    Jung, R.
    Han, M.
    Jung, W.
    Nam, K.
    Kim, Y.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S66 - S66
  • [48] Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects
    Kang, Woo Youl
    Seong, Sook Jin
    Ohk, Boram
    Gwon, Mi-Ri
    Kim, Bo Kyung
    Na, Sookie
    Kim, Hyun-Ju
    Yoon, Young-Ran
    Lee, Hae Won
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (01) : 43 - 52
  • [49] Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
    Oh, Minkyung
    Shin, Jae-Gook
    Ahn, Sangzin
    Kim, Bo Hoon
    Kim, Ji Yeon
    Shin, Hyun Ju
    Ghim, Jong-Lyul
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 991 - 997
  • [50] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects
    Tillmann, Hanns-Christian
    Ethel, Brian
    Abdallah, Nasri
    Machineni, Surendra
    Drollmann, Anton
    Last, Stephanie
    Hahn, Michael
    Radhakrishnan, Rajkumar
    Ignatenko, Stanislav
    Vaidya, Soniya
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345